Efficacy News and Research

RSS
Bacterial enzyme decreases cocaine desire

Bacterial enzyme decreases cocaine desire

New chromosomal screening strategy shows promise in PGS

New chromosomal screening strategy shows promise in PGS

Multivariable analyses identify epidemiological risk factors for ovarian cancer

Multivariable analyses identify epidemiological risk factors for ovarian cancer

Pfizer provides update on Prevnar 13

Pfizer provides update on Prevnar 13

FDA evaluates Phase III randomized trial in acute myeloid leukemia

FDA evaluates Phase III randomized trial in acute myeloid leukemia

Biodel submits NDA to FDA for clearance to market VIAject

Biodel submits NDA to FDA for clearance to market VIAject

Santarus submits rifamycin SV MMX IND to the FDA

Santarus submits rifamycin SV MMX IND to the FDA

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Scientists develop straightforward technique to find ethnic origin of stem cells

Scientists develop straightforward technique to find ethnic origin of stem cells

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Over 5,000 "Not Recommended" Internet drug outlets

Over 5,000 "Not Recommended" Internet drug outlets

Successful RNA interference to turn off multiple genes raises hope for new liver disease treatments

Successful RNA interference to turn off multiple genes raises hope for new liver disease treatments

Promising results from Soligenix' RiVax vaccine against ricin toxin

Promising results from Soligenix' RiVax vaccine against ricin toxin

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Sudden worldwide increase in antibiotic-resistant bacterium, a cause for concern

Sudden worldwide increase in antibiotic-resistant bacterium, a cause for concern

Publication validates company's structure-based approach for addressing undruggable targets

Publication validates company's structure-based approach for addressing undruggable targets

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.